Propiedades antioxidantes de algunas plantas que crecen salvajes en Turquía

In this study, the antioxidant activity of 50% aqueous methanol extracts of 38 plants growing in the Afyonkarahisar province of Turkey were evaluated by various antioxidant assay, including free radical scavenging, hydrogen peroxide (H2O2) scavenging and metal (Fe2+) chelating activities. The methanolic fruit extracts of the Cornus and Morus species (H2O2 and DPPH scavenging activities, Fe2+ chelating activity) and the methanolic leaf extracts of the Mentha species (DPPH scavenging activities) examined in the assay showed the strongest activities. These antioxidant properties depended on the concentration of samples.En este estudio, la actividad antioxidante de extractos metanólicos al 50% en agua de 38 plantas que crecen en la provincia turca de Afyonkarahisar fueron evaluados con algunos ensayos antioxidantes, incluyendo la actividad capta-dora de radicales libres y de peróxido de oxígeno (H2O2) y la actividad quelatante de metales (Fe2+). Los extractos metanólicos de frutas de las especies Cornus y Morus (actividades captadoras de H2O2 y DPPH y actividad quelatante de Fe2+) y los extractos metanólicos de hojas de especies de Mentha (actividad captadora de DPPH) son los que mostraron una actividad mayor. Estas propiedades antioxidantes dependieron de la concentración de la muestra

Effect of pomiferin administration on kidney ischaemia-reperfusion injury in rats

The aim of the study was to analyse protective effects of different doses of pomiferin in therapy of reperfusion injury. Rats were randomly divided into five groups (n=10). One group was intact. Three medicated groups and one placebo group were subjected to ischaemia and reperfusion of the left kidney. Pomiferin was administrated by single gastric gavage in 2 ml of 0.5% Avicel solution in doses of 5, 10 and 20 mg/kg. The placebo group was given only Avicel solution. On day 15, all the animals were exsanguinated and the reperfused kidneys were recovered. Selected biochemical markers were assessed in blood: antioxidative enzymes, total antioxidative capacity, malondialdehyde, creatinine, urea and uric acid. Creatinine, urea and total proteins were analysed in urine and 24-hour diuresis was recorded. The kidney tissue samples were used for histopathological examination

Coffee (Caffeine) consumption and left ventricular function during dipyridamol stres myocardial perfusion GATED SPECT

Abstract Not Availabl

Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease

Objective: To determine oxidative stress by the level of protein carbonyls and total antioxidant status (TAOS), and whether oxidative stress is associated with increased risk of cardiovascular disease in women with polycystic ovary syndrome (PCOS). Design: Controlled clinical study. Setting: University hospital. Patient(s): Thirty women with PCOS and 31 healthy control women. Intervention(s): Biometric measures and blood samples collection. Main Outcome Measure(s): C-reactive protein (CRP), lipid fractions, glucose, protein carbonyls, insulin, and other hormone (gonadotropins, androgens) levels and TOAS were measured. The estimate of insulin resistance was calculated by homeostasis model assessment (HOMA-R). Result(s): The women with PCOS had significantly higher serum fasting insulin, CRP, protein carbonyl levels, HOMA-R, LH levels, and LH/FSH ratios than healthy women. However, TAOS was significantly lower in women with PCOS. TAOS was negatively correlated with fasting insulin, HOMA-R, CRP, and protein carbonyls. Fasting insulin was positively correlated with protein carbonyls. High density lipoprotein (HDL) was inversely associated with fasting insulin, HOMA-R, and protein carbonyls. Conclusion(s): Increased oxidative stress and decreased antioxidant capacity may contribute to the increased risk of cardiovascular disease in women with PCOS, in addition to known risk factors such as insulin resistance, hypertension, central obesity, and dyslipidemia. © 2003 by American Society for Reproductive Medicine

Circulating C-terminal propeptide of Type I collagen (CICP) levels in women with polycystic ovary syndrome

Objective: Collagen type I is abundant in the outer layers of capsular stroma and theca exter-na in the ovary. C-terminal propeptide of Type I collagen (CICP) is the measurable form of type I procol-lagen in serum. Circulating CICP levels are indicative of collagen production. This study was designed to determine the serum levels of CICP and tissue inhibitor of metalloproteinase-1 (TIMP-1) levels in women with Polycystic Ovary Syndrome (PCOS). Material and Methods: This study included twenty-five women with PCOS in the study group and twenty healthy women in the control group. Serum lipid sub-fracti-ons, fasting glucose and insulin, hormone (gonadotropins, androgens), CICP and TIMP-1 levels were me-asured. Homeostasis model assessment (HOMA-IR) was used to estimate insulin resistance. Results: Serum luteinizing hormone (LH) and fasting insulin levels, LH/follicule stimulating hormone (FSH) ratio, free an-drogen index (FAI) and HOMA-IR values were higher in patients with PCOS compared with healthy wo-men. A significant increase in CICP level was observed in subjects with PCOS, and TIMP-1 level was found to be significantly decreased. HOMA-IR value was positively correlated with CICP level, but inver-sely with TIMP-1 level. The best cut-off values for CICP and TIMP-1 were >49.94 ng/mL (sensitivity 92.6% and specificity 65%) and 275.99ng/ml (sensitivity 92.6% and specificity 40%) respectively. Con-clusion: Elevated circulating CICP levels may be associated with thickened tunica albuginea in women with PCOS. However, the exact role of CICP in the pathogenesis of the disease remains to be elucida-ted. © 2012 by Türkiye Klinikleri

Effects of intranasal estradiol treatment on serum paraoxonase and lipids in healthy, postmenopausal women

Background/Aims: Serum lipid concentrations worsen after the menopause because of estrogen deficiency, leading to an increased atherogenic pattern. It is known that serum paraoxonase (PON1) activity prevents the development of atherosclerosis. The aim of this cross-sectional study was to observe the effects of intranasal 17ß-estradiol (300 µg/day) on serum PON1 and lipid levels in healthy postmenopausal women. Methods: 48 healthy, postmenopausal women were enrolled into this cross-sectional study. 28 subjects without an intact uterus and ovaries were using single-dose (300 µg/day) intranasal 17ß-estradiol and 20 subjects with spontaneous natural menopause were not on any hormone therapy. Body mass index (BMI), blood pressure, serum follicle-stimulating hormone, estradiol, fasting glucose, insulin, lipid fractions and PON1 levels were measured. Homeostasis model assessment (HOMA-R) was used to estimate insulin resistance. Results: The higher estradiol, high-density lipoprotein and salt-stimulated paraoxonase (SSP) levels were observed in intranasal 17ß-estradiol users in comparison with non-users. There were no statistically significant differences in BMI, blood pressures, other lipid fractions, basal paraoxonase, arylesterase, fasting glucose and insulin levels, HOMA-R between the groups. SSP was inversely associated with fasting insulin levels and HOMA-R. Conclusion: These observations may suggest that intranasal 17ß-estradiol does not have harmful effects on the PON1 activity and lipid metabolism. Copyright © 2006 S. Karger AG